Publisher: Adis International
ISSN: 0114-9954
Source: Reactions Weekly, Vol.1, Iss.1136, 2007-01, pp. : 13-14
Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.
Abstract
Related content
Efalizumab withdrawal: Psoriatic arthritis in patients with psoriasis: 2 case reports
Reactions Weekly, Vol. 1, Iss. 1154, 2007-01 ,pp. :
Efalizumab: Psoriatic arthritis: 16 case reports
Reactions Weekly, Vol. 1, Iss. 1212, 2008-01 ,pp. :
Efalizumab: Exacerbation of psoriatic arthritis: case report
Reactions Weekly, Vol. 1, Iss. 1130, 2006-01 ,pp. :
Efalizumab withdrawal: Erythroderma: 2 case reports
Reactions Weekly, Vol. 1, Iss. 1238, 2009-01 ,pp. :
Efalizumab/etanercept: First reports of cytomegalovirus infection: 2 case reports
Reactions Weekly, Vol. 1, Iss. 1228, 2008-01 ,pp. :